Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today ... approval of a new drug application for epinephrine injection. The FDA Drug ...

Opens in a new tab or window The FDA expanded the approval of ... (47-56% vs 15-22% with placebo, P<0.001) and endoscopic response (34-36% vs 9-13%, P<0.001) at week 12. And maintenance guselkumab ...

Opens in a new tab or window A report showed that in cancer drug indications that received FDA accelerated ... obtain full approval. Notably, the investigators showed that just 12% of pivotal ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

Meowtel explored advancements in feline medicine, nutrition, and care that are helping the more than 350 million domestic cats worldwide live longer.

The U.S. Supreme Court is gearing up to hear Kennedy v. Braidwood Management Inc., a case that could effectively sever access to cost-free preventive care services — including PrEP.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

The Citizens Commission on Human Rights International (CCHR), a leading mental health industry watchdog, has released a damning report detailing how ...

Q4 2024 Earnings Call Transcript March 31, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, ...

HEAL seeks to provide investors exposure to the growing HealthTech industry, which is expected to grow fourfold from $225 billion in 2022 to over $1 trillion by 2032.